In this study, we clarified the role of cancer cell-derived miR-124 in bone metastases from breast cancer and identified that perturbation of the miR-124/IL-11 regulatory axis contributes to the bone metastasis observed in breast cancer. The gene discussed is IL11; the disease is breast carcinoma.